Motor, emotional and cognitive deficits in adult BACHD mice: A model for Huntington's disease

被引:35
作者
Abada, Yah-se K. [1 ,2 ]
Schreiber, Rudy [3 ]
Ellenbroek, Bart [4 ]
机构
[1] EVOTEC AG, D-22419 Hamburg, Germany
[2] Univ Bremen, Brain Res Inst, Dept Neuropharmacol, D-28334 Bremen, Germany
[3] Univ Groningen, NL-9700 AB Groningen, Netherlands
[4] Victoria Univ Wellington, Sch Psychol, Wellington 6140, New Zealand
关键词
Anxiety; Catwalk; Fear conditioning; Huntington's disease; Strategy shifting; Transgenic mice; CATWALK GAIT ANALYSIS; MUTANT HUNTINGTIN; MOUSE MODELS; NEUROPSYCHOLOGICAL DEFICITS; 3-NITROPROPIONIC ACID; GENE CARRIERS; IN-VITRO; PLACE; STRIATUM; RAT;
D O I
10.1016/j.bbr.2012.10.039
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Rationale: Huntington's disease (HD) is characterized by progressive motor dysfunction, emotional disturbances and cognitive deficits. It is a genetic disease caused by an elongation of the polyglutamine repeats in the huntingtin gene. Whereas HD is a complex disorder, previous studies in mice models have largely been confined to assessing motor deficits. Objectives: The aim of the present studies is a comprehensive phenotypical assessment of not only motor and gait deficits, but also of emotional and cognitive deficits in adult BACHD mice. Material and methods: 46 male BACHD mice between 9 and 10 months of age were used. Wild type (+/+) and transgenic (+/T) mice were tested for motor deficits on a Rotarod and Catwalk system. Emotional deficits were assessed with the zero-maze and fear conditioning tests. Cognitive deficits in a strategy shifting task were evaluated in a cross-maze test. Results: Comparing +/T and +/+ mice, we replicated the motor deficits in the transgenic mice that were previously described in the Rotarod test. For the first time, motor coordination imbalances in +/T animals are described in the Catwalk gait analysis system. +/T mice showed more anxiety-like behavior in the zero-maze test and a higher freezing response in the fear conditioning test. Reversal and strategy shifting impairments were demonstrated in the cross-maze, indicative of a disturbed prefrontal striatal pathway. Conclusion: The results suggest that BACHD mice represent an animal model with a high degree of face validity for HD and may be very useful for testing novel therapeutic strategies. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:243 / 251
页数:9
相关论文
共 50 条
  • [21] Motivational Impairment is Accompanied by Corticoaccumbal Dysfunction in the BACHD-Tg5 Rat Model of Huntington's Disease
    Zlebnik, Natalie E.
    Gildish, Iness
    Sesia, Thibaut
    Fitoussi, Aurelie
    Cole, Ellen A.
    Carson, Brian P.
    Cachope, Roger
    Cheer, Joseph F.
    CEREBRAL CORTEX, 2019, 29 (11) : 4763 - 4774
  • [22] Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease
    Emerich, DF
    Cain, CK
    Greco, C
    Saydoff, JA
    Hu, ZY
    Liu, HJ
    Lindner, MD
    CELL TRANSPLANTATION, 1997, 6 (03) : 249 - 266
  • [23] Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease
    Sebastianutto, Irene
    Cenci, Maria Angela
    Fieblinger, Tim
    NEUROBIOLOGY OF DISEASE, 2017, 105 : 117 - 131
  • [24] Altered reactivity of central amygdala to GABAAR antagonist in the BACHD rat model of Huntington disease
    Lamirault, Charlotte
    Yu-Taeger, Libo
    Doyere, Valerie
    Riess, Olaf
    Huu Phuc Nguyen
    El Massioui, Nicole
    NEUROPHARMACOLOGY, 2017, 123 : 136 - 147
  • [25] Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease
    Palfi, SP
    Ferrante, RJ
    Brouillet, E
    Beal, MF
    Dolan, R
    Guyot, MC
    Peschanski, M
    Hantraye, P
    JOURNAL OF NEUROSCIENCE, 1996, 16 (09) : 3019 - 3025
  • [26] Circadian-based Treatment Strategy Effective in the BACHD Mouse Model of Huntington's Disease
    Whittaker, Daniel S.
    Loh, Dawn H.
    Wang, Huei-Bin
    Tahara, Yu
    Kuljis, Dika
    Cutler, Tamara
    Ghiani, Cristina A.
    Shibata, Shigenobu
    Block, Gene D.
    Colwell, Christopher S.
    JOURNAL OF BIOLOGICAL RHYTHMS, 2018, 33 (05) : 535 - 554
  • [27] Early cognitive deficits in Swedish gene carriers of Huntington's disease
    Wahlin, Tarja-Brita Robins
    Lundin, Anders
    Dear, Keith
    NEUROPSYCHOLOGY, 2007, 21 (01) : 31 - 44
  • [28] Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease
    Zadori, Denes
    Geisz, Andrea
    Vamos, Eniko
    Vecsei, Laszlo
    Klivenyi, Peter
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2009, 94 (01) : 148 - 153
  • [29] Beyond Motor Deficits: Environmental Enrichment Mitigates Huntington's Disease Effects in YAC128 Mice
    Placido, Evelini
    Gomes Welter, Priscilla
    Wink, Ana
    Karasiak, Gabriela Duarte
    Outeiro, Tiago Fleming
    Dafre, Alcir Luiz
    Gil-Mohapel, Joana
    Brocardo, Patricia S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [30] Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice
    Tong, Xiaoping
    Ao, Yan
    Faas, Guido C.
    Nwaobi, Sinifunanya E.
    Xu, Ji
    Haustein, Martin D.
    Anderson, Mark A.
    Mody, Istvan
    Olsen, Michelle L.
    Sofroniew, Michael V.
    Khakh, Baljit S.
    NATURE NEUROSCIENCE, 2014, 17 (05) : 694 - +